Direct evidence for a continuous immune-priming defect in laryngeal squamous cell carcinoma (LSCC) remains incomplete. This Review therefore does not treat failed priming as an established LSCC mechanism. Instead, it separates direct LSCC observations from evidence derived from mixed-site head and neck squamous cell ca...
Wei-Zhe Hong, Guan-Jiang Huang, Qing Luo et al.· Frontiers in Immunology· 0 citations
It is argued that combining MDSC-targeting strategies with PD-1 blockade merits dedicated clinical investigation in this disease and supported MDSCs as a clinically tractable immunosuppressive node in LSCC.
Guan-Jiang Huang, Xue-Sen Yang, Peijie Li et al.· Frontiers in Immunology· 1 citation
An evidence-stratified framework for CAF heterogeneity in LSCC is established and clarifies the translational value and current limitations of stroma-targeted strategies and provides a structured foundation for hypothesis-driven clinical and experimental investigation in laryngeal cancer.
Wei-Zhe Hong, Guan-Jiang Huang, Qing Luo et al.· Frontiers in Immunology· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.